BACKGROUND: Coronary artery (CA) Z-score system is widely used to define CA aneurysm (CAA). Children and adolescents after acute stage of Kawasaki disease (KD-CA) have a higher risk of developing CAAs if their CA Z-scoreââ¥â2.5. Z-score system of peak oxygen consumption (Peak VO(2) Z-score) allows comparisons across ages and sex, regardless of body size and puberty. We aimed to compare the exercise capacity (EC) indicated by peak VO(2) Z-score during cardiopulmonary exercise testing (CPET) directly between KD-CA with different CA Z-score. METHODS: KD-CA after acute stage who received CPET in the last 5 years were retrospectively recruited. CA Z-score was based on Lambda-Mu-Sigma method. Max-Z was the maximum CA Z-score of different CAs. KD children with Max-Zâ<â2.5 andââ¥â2.5 were defined as KD-1 and KD-2 groups, respectively. Peak VO(2) Z-score was calculated using the equation established based on Hong Kong Chinese children and adolescent database. RESULTS: One hundred two KD-CA were recruited (mean age: 11.71â±â2.57 years). The mean percent of measured peak VO(2) to predicted value (peak PD%) was 90.11â±â13.33. All basic characteristics and baseline pulmonary function indices were comparable between KD-1 (nâ=â87) and KD-2 (nâ=â15). KD-1 had significantly higher peak VO(2) Z-score (pâ=â.025), peak PD% (pâ=â.008), peak metabolic equivalent (pâ=â.027), and peak rate pressure product (pâ=â.036) than KD-2. CONCLUSIONS: KD-CA had slightly reduced EC than healthy peers. KD-CA with Max-Zââ¥â2.5 had significantly lower peak EC than thoseâ<â2.5. Max-Z is potentially useful follow-up indicator after acute stage of KD.
When two Z-scores meet-analysis of exercise capacity of children and adolescents with Kawasaki disease by a new Z-score model of coronary artery and a new Z-score evaluating peak oxygen consumption : Coronary artery Z-score and peakVO2 Z-score in KD.
阅读:4
作者:Tuan Sheng-Hui, Chung Jin-Hui, Chen Guan-Bo, Sun Shu-Fen, Liou I-Hsiu, Li Chien-Hui, Tsai Yi-Ju
| 期刊: | Italian Journal of Pediatrics | 影响因子: | 3.100 |
| 时间: | 2023 | 起止号: | 2023 Sep 29; 49(1):129 |
| doi: | 10.1186/s13052-023-01535-3 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
